Renuvion may be used to coagulate subcutaneous soft tissue after liposuction in selected body-contouring patients. It does not remove substantial excess skin, replace an abdominoplasty or body lift, or function as a facelift or neck lift.
The device and its indication should be named clearly
Renuvion, also called J-Plasma, combines radiofrequency energy with helium plasma. The handpiece, treatment plane and intended use matter. In April 2023, the US Food and Drug Administration cleared the Renuvion APR handpiece for coagulation of subcutaneous soft tissue following liposuction for aesthetic body contouring.
Regulatory clearance does not mean that every anatomical area, technique or promotional claim has been evaluated. Patients should ask which handpiece will be used, where it will be applied and whether that use matches the device instructions.
What Renuvion may and may not change
| Finding | Possible role | Limitation |
|---|---|---|
| Mild residual laxity after fat removal | Selected adjunct to liposuction | The degree of contraction varies |
| Substantial loose skin | Usually limited benefit | Excisional surgery may be required |
| Muscle separation or abdominal-wall laxity | No corrective role | Requires a different anatomical treatment |
| Facial or neck descent | Not a substitute for lifting surgery | Does not reposition SMAS, platysma or retaining ligaments |
The indication depends on skin quality, amount and distribution of fat, previous operations, scars and the expected effect of liposuction alone. A device should not be added merely because it is available.
Energy-based treatment has specific complications
Reported risks include burns, gas accumulation, subcutaneous emphysema, contour irregularity, pain, numbness, prolonged swelling, infection and tissue injury. Liposuction adds its own risks, including bleeding, seroma, fluid imbalance, thrombosis and anaesthetic complications.
The FDA advises clinicians to follow the handpiece instructions and training requirements and to discuss alternative procedures. Appropriate cannula movement, treatment plane and energy delivery are technical safety issues, not marketing details.
Recovery follows the complete operation
Bruising, swelling, tenderness and temporary sensory change may occur. Compression garments and activity restrictions depend on the anatomical area and the liposuction plan. The visible contour changes as swelling resolves over weeks to months; early tightness does not predict the final result.
Increasing pain, blistering, skin colour change, fever, shortness of breath, chest pain or rapidly expanding swelling requires urgent evaluation.
International planning must include surgical contingency
Patients travelling to Brazil need medical screening, medication review, an appropriate hospital or surgical facility, postoperative examination and a plan for care after returning home. The Belvivere Concierge can coordinate accommodation and transport but does not replace clinical monitoring.
Renuvion is not part of Dr. June Favarin’s facial-lifting framework. Facial laxity should be assessed by region and anatomical layer; see the guide to choosing facial procedures by anatomy.
